Quebec prostate cancer mortality dropped in 1996.
OBJECTIVE
To monitor incidence and mortality rates of prostate cancer in the province of Quebec.


METHODS
Population-based incidence and mortality trends.


METHODS
Entire population of the province of Quebec between 1979 and 1996.


METHODS
Age-standardized incidence rates and mortality for prostate cancer.


RESULTS
Prostate cancer mortality increased regularly until 1989, were stable between 1989 and 1995 and dropped in 1996 by 15%. Incidence rates increased steadily from 1989 until 1993 by an average of 9% per year.


CONCLUSIONS
The rise in incidence is due to the increasing use of prostate specific antigen as a screening test for prostate cancer. The reasons for the reduction in prostate cancer mortality are unknown but are likely to reflect improved treatment modalities.
Meyer
F
F
Department of Social and Preventive Medicine, Faculty of Medicine, Laval University, Sainte-Foy, Que. fmeyer@gre.ulaval.ca
Moore
L
L
Bairati
I
I
Fradet
Y
Y
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D016001:Confidence Intervals; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000401:mortality*; D011792:Quebec / Q000453:epidemiology; D012044:Regression Analysis
D017430:Prostate-Specific Antigen